Pharmaceutical QSAR studies

It is not yet possible to design a molecule with specific odor (or taste) characteristics because the relations between sensory properties of flavor compounds and their molecular properties are not well understood. As a consequence, the development of compounds with desired flavor qualities has had to rely on relatively tedious synthetic approaches. Recent advances, however, in computer-based methods developed by the pharmaceutical industry to study QSAR (quantitative structure-activity relationships) may ultimately be helpful in the rational design of new flavor-structures with predictable sensory attributes. Results from QSAR studies may also provide insight into the mechanism of the molecule-receptor interaction. 

Injection. Except for certain pharmaceuticals and drugs of abuse, injection (parenteral administration) does not correspond to any of the expected modes of exposure. Injection may be useful, however, in mechanistic studies or in QSAR studies in order to bypass absorption and/or permit rapid action. Methods of injection include intravenous (IV), intramuscular (IM), intraperitoneal (IP), and subcutaneous (SC). Infusion of test... 

Certain other classes of compounds, e.g., dihydropyridines (7-9) and phenylsulfonylindolizines (10,11), have also been studied for CCB activity. In these also, the hydrophobicity and steric factors have been found to play the important roles. Thus, QSAR studies have provided valuable information for the design of potent calcium channel blockers of pharmaceutical importance. 

Zhao et at, Journal of Pharmaceutical Sciences, 2002 Rate-limited steps of human oral absorption and QSAR studies 238 MLR, MNLR n.af Abraham descriptors (u — 5)... 

Pharmaceutical companies and other researchers trying to identify new drugs for the marketplace often use computational chemistry quantitative structure-activity relationships (QSARs) studies to examine the relationship of activity and smaU structural changes. This is a complicated, complex, and expensive method but this is almost always cheaper than using test compounds in whole animals and has been successful in limited cases. It continues to remain a highly active area of research. 

Theoretical calculations can also provide physicochemical data, which can be used as an input for 3D-QSAR correlation studies [134,141]. There is a current trend in the area of lead-finding in the pharmaceutical industry to use calculations to set up computer search profiles to be used in the screening of large structural databases, such as the chemical suppliers databases and the internal company databases. 

When using QSAR calculations to optimize a drug for the pharmacodynamic phase, it is important to use relevant biological activities. If in vivo activities are used, the bioactivities will be influenced by pharmacokinetic and pharmaceutical factors. In order for QSAR calculations to reflect the pharmacodynamic phase, the bioactivities should be based on in vitro data — optimally, receptor binding studies. 

Odor and taste quality can be mapped by multidimensional scaling (MDS) techniques. Physicochemical parameters can be related to these maps by a variety of mathematical methods including multiple regression, canonical correlation, and partial least squares. These approaches to studying QSAR (quantitative structure-activity relationships) in the chemical senses, along with procedures developed by the pharmaceutical industry, may ultimately be useful in designing flavor compounds by computer. 

The criticisms in the previous paragraphs lead to a question If Hansch analysis is of such questionable value, then why has an entire chapter of this textbook been devoted to the subject Despite the fading utility of classical QSAR methods such as Hansch analysis, the logic behind Hansch analysis is invaluable to medicinal chemistry. Synthetic chemists in the pharmaceutical industry intuitively consider the ideas used to construct Hansch equations. Ideas such as electronics, sterics, and lipophilicity underlie traditional SAR approaches in the laboratory. Critical analysis of activity data and emphasis on seeking holes in R-group selection are also fundamental to successful SAR on a lead. Through the study of Hansch analysis, all these crucial ideas are presented in a rational framework that helps demonstrate their relevance. Just as importantly, Hansch analysis provides the foundation for the next generation of QSAR comparative molecular field analysis. 

A QSAR seeks to relate quantitative properties (descriptors) of a compound with other properties such as drug-like activity or toxicity. The essential assumption of QSAR is that quantities that can be conveniently measured or calculated for a compound can be used to accurately predict another property of interest (e.g., antibacterial activity) in a nontrivial way. QSAR has become an integral part of screening programs in pharmaceutical drug-discovery pipelines of small compounds and more recently in toxicological studies (69). However, the use of QSAR modeling applied to the search for antimicrobial peptides is relatively recent. Advances in this area are reviewed in brief here. 

This new family of oxazolidinones was described and shown to effectively displace compounds that bind the ribosomal 50S A-site (linezolid site), including chloramphenicol and Puromycin [80]. The structures of several family members (16-20) are depicted in Scheme 3. The reader is referred to the primary citations for tables of antibacterial activity data (as is the case for all case studies). Compounds such as 17 and 19 were compounds predicted to have good oral bioavailability in the QSAR model [79]. Compounds such as 16 were predicted to have good Haemophilus influenzae activity in that QSAR activity model [79]. The computational and crystallographically inspired design of novel oxazolidinones eventually led to Rib-X Pharmaceuticals clinical candidate, Radezolid (20), currently in Phase II clinical trials [31]. 

---